Eads, J. R., Morelli, M. P., Olson, D., Litten, J. B., Astrow, S. H., Pelster, M. (2025). A phase 1/2 study to evaluate CHM-2101, an autologous cadherin 17 (CDH17) chimeric antigen receptor (CAR) T cell therapy for the treatment of relapsed or refractory gastrointestinal cancers.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps844